References
- Banker, MJ , Clark, TH , and Williams, JA , 2003. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding , Journal of Pharmaceutical Science 92 (2003), pp. 967–974.
- Clarke, SE , and Jeffrey, P , 2001. Utility of metabolic stability screening: Comparison of in vitro and in vivo clearance , Xenobiotica 31 (2001), pp. 591–598.
- Davies, B , and Morris, T , 1993. Physiological parameters in laboratory animals and humans , Pharmaceutical Research 10 (1993), pp. 1093–1095.
- Evans, CA , Jolivette, LJ , Nagilla, R , and Ward, KW , 2006. Extrapolation of preclinical pharmacokinetics and molecular feature analysis of ‘discovery-like’ molecules to predict human pharmacokinetics , Drug Metabolism and Disposition 34 (2006), pp. 1255–1265.
- Kameoka, N , Nimura, Y , Sato, T , Kato, M , Yasui, A , and Kondo, S , 1996. Postprandial responses of liver blood flow prior to and following hepatectomy in conscious dogs , Journal of Surgical Research 61 (1996), pp. 437–443.
- Kelland, LR , 2004. ‘Of mice and men’: Values and liabilities of the athymic nude mouse model in anticancer drug development , European Journal of Cancer 40 (2004), pp. 827–836.
- Kurosawa, M , Unno, T , Yoshihiro, AY , and Yoneda, M , 2002. Neural regulation of hepatic blood flow in rats: An in vivo study , Neuroscience Letters 321 (2002), pp. 145–148.
- Mahmood, I , and Sahajwalla, C , 2002. Interspecies scaling of biliary excreted drugs , Journal of Pharmaceutical Science 91 (2002), pp. 1908–1914.
- Obach, RS , 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes , Drug Metabolism and Disposition 27 (1999), pp. 1350–1359.
- Royo, F , Carlsson, H-E , Mayo, S , and Hau, J , 2004. Impact of chronic catheterization and automated blood sampling (Accusampler) on serum coritcosterone and fecal immunoreactive corticosterone metabolites and immunoglobulin A in male rats , Journal of Endocrinology 180 (2004), pp. 145–153.
- Shiran, MR , Proctor, NJ , Howgate, EM , Rowland-Yeo, K , Tucker, GT , and Rostami-Hodjegan, A , 2006. Prediction of metabolic drug clearance in humans: In vitro–in vivo extrapolation vs. allometric scaling , Xenobiotica 36 (2006), pp. 567–580.
- Tang, H , Hussain, A , Leal, M , Mayersohn, M , and Fluhler, E , 2007. Interspecies prediction of human drug clearance based on scaling data from one or two animal species , Drug Metabolism and Disposition 35 (2007), pp. 1886–1893.
- Tomaszewski, JE , 2004. Multi-species toxicology approaches for oncology drugs: The US perspective , European Journal of Cancer 40 (2004), pp. 907–913.
- Woo, S , and Jusko, WJ , 2007. Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin , Drug Metabolism and Disposition 35 (2007), pp. 1672–1678.
- Xiang, H , McSurdy-Freed, J , Moorthy, GS , Hugger, E , Bambal, R , Han, C , Ferrer, S , Gargallo, D , and Davis, CB , 2006. Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor , Journal of Pharmaceutical Science 95 (2006), pp. 2657–2672.